My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Xoma Corp (XOMA)
NASDAQ:XOMA

Xoma Stock Analysis & Ratings

Xoma Stock Analysis Overview

Smart Score
6
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Xoma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

XOMA

XOMA Stock Stats

Previous Close$25.5
Open$25.83
Bid0 x 0
Ask0 x 0
Today’s Range$25.47 - $25.9764
52-Week Range$19.25 - $46.32
Volume13.18K
Average Volume27.62K
Market Cap$291.72M
Beta0.93
P/E Ratio46.1
EPS0.56
Earnings DateNov 10, 2021

Company Description

Xoma Corp

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
Sector
Healthcare
Industry
Biotechnology
CEO
James R. Neal
Employees
11
ISIN
US98419J2069
Address
2200 Powell Street, Emeryville, CA, 94608, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

XOMA FAQ

What was Xoma’s price range in the past 12 months?
Xoma lowest stock price was $19.25 and its highest was $46.32 in the past 12 months.
    What is Xoma’s market cap?
    Xoma’s market cap is $291.72M.
      What is Xoma’s price target?
      The average price target for Xoma is $49.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $69.00 ,the lowest forecast is $22.00. The average price target represents 90.00% Increase from the current price of $25.79.
        What do analysts say about Xoma?
        Xoma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Xoma’s upcoming earnings report date?
          Xoma’s upcoming earnings report date is Nov 10, 2021 which is in 23 days.
            How were Xoma’s earnings last quarter?
            Xoma released its earnings results on Aug 05, 2021. The company reported -$0.313 earnings per share for the quarter, beating the consensus estimate of -$0.345 by $0.032.
              Is Xoma overvalued?
              According to Wall Street analysts Xoma’s price is currently Undervalued.
                Does Xoma pay dividends?
                Xoma does not currently pay dividends.
                What is Xoma’s EPS estimate?
                Xoma’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Xoma have?
                Xoma has 11,310,000 shares outstanding.
                  What happened to Xoma’s price movement after its last earnings report?
                  Xoma reported an EPS of -$0.313 in its last earnings report, beating expectations of -$0.345. Following the earnings report the stock price went up 2.918%.
                    Which hedge fund is a major shareholder of Xoma?
                    Currently, no hedge funds are holding shares in XOMA

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis